The use of TEVAR as a bridge to definitive repair in the management of a recurrent aorto-oesophageal fistula
Terri-Ann Russell, Maher Hamish.
Northampton General Hospital, Northampton, United Kingdom.
Objective: The purpose of this study is to prove that TEVAR is an acceptable bridging therapy for the acute management of an aorto-oesophageal fistula
Method: A retrospective approach was used to assess the management of a patient with recurrent aorto-oesophageal fistula from initial management to definitive aorto-oesophageal repair
Results: The definitive role of TEVAR in the management of AEFs is still undefined. It however provides a rapid means to achieve haemodynamic stability and is associated with low morbidity and mortality
Conclusion: TEVAR is an excellent bridging therapy and a possible definitive therapy for patients with haematemesis and those who are high risk for surgery or have advanced cancer respectively. The main deterrent to the use of this technique is the presumed risk of ongoing contamination of the stent-graft which increases the risk of sepsis.
Back to 2018 ePosters
